Clinical Trial Update: Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing how nicotinic acid affects endothelial vasomotricity in patients with acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Nicotinic acid (niacin)

Snippet

Sponsor: French Cardiology Society | Conditions: Acute Coronary Syndrome (ACS) | Phase 3 | Status: COMPLETED